Skip to main content
. 2018 Feb 22;20(3):280–288. doi: 10.1016/j.neo.2018.01.007

Figure 3.

Figure 3

Progression-free survival from first to second recurrence (PFS2) in dependence of TILs levels (A-C) and MHC expression (D, E). There was a trend towards longer PFS2 in recurrent tumors with high CD4+ TILs densities (B). MHC2 expression was significantly linked to longer PFS2 in recurrent HGSOC (E).